ctrl K

Watchlist Price Alert

Aardvark Therapeutics Inc... (AARD)

NASDAQ: AARD · Real-Time Price · USD

13.79

0.27 (2.03%)

At close: Jul 01, 2025, 3:51 PM

Aardvark Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q4 2023	Q3 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Dec 31, 2023	Sep 30, 2023
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a
Operating Income	-27.24M	-18.49M	-9.04M	-3.95M	-1.72M
Interest Income	1.83M	1.97M	1.25M	253K	135K
Pretax Income	-24.31M	-17.11M	-8.33M	-4.15M	-2.11M
Net Income	-24.31M	-17.11M	-8.33M	-4.15M	-2.11M
Selling & General & Admin	5.65M	3.48M	2.09M	1.06M	538K
Research & Development	21.42M	14.63M	6.57M	2.5M	964K
Other Expenses	171K	388K	388K	388K	217K
Operating Expenses	27.24M	18.49M	9.04M	3.95M	1.72M
Interest Expense	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	16.77M	18.49M	9.04M	3.95M	1.72M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	13.19M	12.91M	12.91M	9.73M	9.73M
Shares Outstanding (Diluted)	13.19M	12.91M	12.91M	9.73M	9.73M
EPS (Basic)	-1.92	-1.43	-0.75	-0.43	-0.22
EPS (Diluted)	-1.92	-1.43	-0.75	-0.43	-0.22
EBITDA	-26.94M	-17.95M	-8.5M	-3.49M	-1.48M
EBIT	-15.93M	-17.43M	-8.65M	-3.56M	-1.5M
Depreciation & Amortization	-9K	17K	138K	51K	26K